Amgen's Q1 CY2025 revenue exceeded expectations, with sales up 9.4% to $8.15 billion. The company foresees full-year revenue around $35 billion, in line with analysts' estimates.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Amgen's (NASDAQ:AMGN) Q1: Beats On Revenue
